Abstract

By analyzing COVID-19 sequential COVID-19 test results of patients across the United States, we herein attempt to quantify some of the observations we've made around long-term infection (and false-positive rates), as well as provide observations on the uncertainty of sampling variability and other dynamics of COVID-19 infection in the United States. Retrospective cohort study of a registry of RT-PCR testing results for all patients tested at any of the reference labs operated by Labcorp® including both positive, negative, and inconclusive results, from March 1, 2020 to January 28, 2021, including patients from all 50 states and outlying US territories. The study included 22 million patients with RT-PCR qualitative test results for SARS-CoV-2, of which 3.9 million had more than one test at Labcorp. We observed a minuscule <0.1% basal positive rate for follow up tests >115 days, which could account for false positives, long-haulers, and/or reinfection but is indistinguishable in the data. In observing repeat-testing, for patients who have a second test after a first RT-PCR, 30% across the cohort tested negative on the second test. For patients who test positive first and subsequently negative within 96 h (40% of positive test results), 18% of tests will subsequently test positive within another 96-h span. For those who first test negative and then positive within 96 h (2.3% of negative tests), 56% will test negative after a third and subsequent 96-h period. The sudden changes in RT-PCR test results for SARS-CoV-2 from this large cohort study suggest that negative test results during active infection or exposure can change rapidly within just days or hours. We also demonstrate that there does not appear to be a basal false positive rate among patients who test positive >115 days after their first RT-PCR positive test while failing to observe any evidence of widespread reinfection.

Highlights

  • Examining the repeat-testing results of reverse transcription polymerase chain reaction (RTPCR) testing for COVID-19 via nasal, nasopharyngeal, or oropharyngeal swab can help to derive population-level testing sensitivity and specificity levels as well as search for evidence of various logistical or operational false positives and negatives that could be systemic in nature [1]

  • The registry maintained by Labcorp includes 29.8 million SARS-CoV-2 PCR tests conducted through multiple channels, including physician ordered, drive-through testing sites, employer/government contracts, and Pixel by Labcorp (Labcorp’s at-home PCR test offering)

  • Patients include a wide representation of the United States and specimen collections during the entire pandemic duration

Read more

Summary

Introduction

Examining the repeat-testing results of reverse transcription polymerase chain reaction (RTPCR) testing for COVID-19 via nasal, nasopharyngeal, or oropharyngeal swab can help to derive population-level testing sensitivity and specificity levels as well as search for evidence of various logistical or operational false positives and negatives that could be systemic in nature [1]. Follow-Up SARS-CoV-2 PCR Testing testing in the literature survey, a study out of Singapore showed that the combination of RT-PCR and chest tomography (CT) has higher sensitivity (91.9%,79/86) than RT-PCR alone (78.2%, 68/87), CT alone (66.7%, 54 of 81) or combination of two RTPCR tests (86.2%, 75/87) [6]. We use repeat-testing outcomes to attempt to quantify some of the population-level false positive and false negative rates for various time points. In one study examining repeat testing of head/neck injury surgeries in acute care settings, 43 of 52 patients required two or more preoperative PCR tests. In the case of an 81-year-old female who underwent urgent coronary artery bypass grafting and was readmitted following discharge to a nursing facility with a cluster of COVID-19 cases, despite symptomatology and imaging concerns for COVID-19, her two initial RT-PCR tests were negative, but a third test was positive [9]

Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call